Literature DB >> 11205495

Breast cancer risk and "delayed" primary Epstein-Barr virus infection.

Y Yasui1, J D Potter, J L Stanford, M A Rossing, M D Winget, M Bronner, J Daling.   

Abstract

Parallel to its established causal association with both infectious mononucleosis (IM) and young adulthood Hodgkin disease (YAHD), we propose a hypothesis that "delayed" primary EBV infection (i.e., primary infection occurring during adolescence or adulthood) is associated with elevated breast cancer risk. We evaluated this hypothesis with two investigations, one descriptive and the other analytic. The descriptive study used international/United States cancer registry data to assess the association between incidence rates of breast cancer and those of YAHD. The incidence rates of the seemingly unrelated neoplasms were strongly correlated (correlation coefficients of 0.74 and 0.88 for international and United States data, respectively; these were higher than the correlation coefficients of YAHD with two other cancers that we considered). Populations with higher incidence rates corresponded to those with higher likelihood of delayed primary EBV infection. The analytical study was based on a population-based case-control study of breast cancer in middle-aged women. Age-adjusted odds ratios of breast cancer in women who reported a history of IM, relative to women who did not, increased monotonically from 0.55 [95% confidence interval (CI), 0.05-6.17] for women with 0-9 years of age at IM onset to 2.67 (CI, 1.04-6.89) for women with > or =25 years of age at IM onset (P = 0.016). An older age at tonsillectomy, another surrogate of delayed EBV exposure, was also associated with increased risk of breast cancer: odds ratios, 0.92 (CI, 0.57-1.48) and 1.76 (CI, 1.15-2.69) for women with tonsillectomy at 0-4 years of age and > or =15 years of age, respectively (P = 0.018). Adjusting for additional potential confounders did not modify the associations appreciably. The implications of the findings and a potential biological mechanism are presented.

Entities:  

Mesh:

Year:  2001        PMID: 11205495

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

Review 1.  Breast cancer and cytomegalovirus.

Authors:  A K Richardson; L C Walker; B Cox; H Rollag; B A Robinson; H Morrin; J F Pearson; J D Potter; M Paterson; H-M Surcel; E Pukkala; M J Currie
Journal:  Clin Transl Oncol       Date:  2019-06-29       Impact factor: 3.405

2.  Case report of concurrent primary malignancies of the breast and nasopharynx.

Authors:  Xinbin Pan; Xiaodong Zhu; Qingdi Quentin Li
Journal:  Oncol Lett       Date:  2012-05-15       Impact factor: 2.967

3.  Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women.

Authors:  Deepti Joshi; Munira Quadri; Neha Gangane; Rajnish Joshi; Nitin Gangane
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

4.  Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.

Authors:  B Cox; A Richardson; P Graham; R E Gislefoss; E Jellum; H Rollag
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

Review 5.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 6.  The possible involvement of virus in breast cancer.

Authors:  Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-14       Impact factor: 4.553

7.  Epstein-Barr virus as a marker of biological aggressiveness in breast cancer.

Authors:  C Mazouni; F Fina; S Romain; L Ouafik; P Bonnier; J-M Brandone; P-M Martin
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

8.  Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer.

Authors:  Wendy K Glenn; Benjamin Heng; Warick Delprado; Barry Iacopetta; Noel J Whitaker; James S Lawson
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa.

Authors:  Issoufou Tao; Cyrille Bisseye; Bolni Marius Nagalo; Mahamoudou Sanou; Alice Kiba; Guzin Surat; Tegwindé Rebeca Compaoré; Lassina Traoré; Jean Baptiste Nikiema; Virginio Pietra; Jean-Didier Zongo; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

10.  Presence of HPV, EBV and HMTV Viruses Among Egyptian Breast Cancer Women: Molecular Detection and Clinical Relevance.

Authors:  Shimaa A Metwally; Maha A Abo-Shadi; Nasra F Abdel Fattah; Ahmed B Barakat; Omar A Rabee; Ahmed M Osman; Amany M Helal; Tarek Hashem; Manar M Moneer; Wassim Chehadeh; Samah A Loutfy
Journal:  Infect Drug Resist       Date:  2021-06-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.